You've been invited to join Citizen Health
New: Citizen Health's Mobile App is now available on iPhone in the US
Read more

The path to clinical trial & commercial success starts with connecting to patients

We power smarter trial design, recruitment, and post-market evidence with regulatory-grade data and engaged patient communities

Not your typical RWD vendor

Informed and empowered, our patient communities consent to share complete medical histories to advance better treatments

  • Regulatory-grade, longitudinal data

    Submission-ready datasets accepted by FDA to replace traditional in-person study requirements

  • Comprehensive medical history

    Unifies unstructured medical records, genetics, and imaging across systems from birth or diagnosis

  • High-density patient communities

    Built with 70+ long-term advocacy partners - enabling trusted, aligned engagement

  • Recontactable, engaged patients

    Trusted relationships enable recontact for faster recruitment and effective long-term follow-up

From complexity to clarity: explore our case studies

11 case studies available from pre-IND, clinical trial, to post-marketing

Three case study cards: 1) Seizure frequency decreases with age, recommending prioritizing ages 17+ for trial endpoints. 2) Graph comparing randomized trial and external control arm populations showing credible control with clinical-grade matched data. 3) US map showing precise geographical patient clusters matching inclusion/exclusion criteria for eligible patients.
Download Now

Have a similar challenge?
Let's talk

Book 15 minutes

We are proud to partner with leading biotech and pharma companies and universities

Logos of pharmaceutical and medical research partners including AstraZeneca, Novartis, Biogen, Emory University, University of Arizona, UCSF, St. Jude Children's Research Hospital, Ionis, Children's Hospital of Philadelphia, Rocket Pharma, Praxis, MAHZ Therapeutics, Servier, Jazz Pharmaceuticals, Taysha Gene Therapies, Neurogene, Zynerba Pharmaceuticals, Actio Biosciences, Atalanta Therapeutics, Avidity Biosciences, and UCB Pharma.